Literature DB >> 16051597

Fibrin but not adsorbed fibrinogen supports fibronectin assembly by spread platelets. Effects of the interaction of alphaIIb beta3 with the C terminus of the fibrinogen gamma-chain.

Jaehyung Cho1, Jay L Degen, Barry S Coller, Deane F Mosher.   

Abstract

We investigated the assembly of soluble fibronectin by lysophosphatidic acid-activated platelets adherent to fibrinogen or fibrin. More fibronectin was assembled by activated platelets spread on fibrin matrices than by platelets spread on adsorbed fibrinogen. The difference between platelets adherent to fibrinogen and fibrin occurred under both static and flow conditions. Similar differences were seen in binding of the 70-kDa N-terminal fragment of fibronectin that recognizes fibronectin assembly sites on adherent cells. Antibody and peptide blocking studies demonstrated that alphaIIb beta3 integrin mediates platelet adhesion to fibrinogen, whereas both alphav beta3 and alphaIIb beta3 mediate platelet adhesion to fibrin. The hypothesis that engagement of the C-terminal QAGDV sequence of the fibrinogen gamma-chain by alphaIIb beta3 inhibits the ability of the platelet to assemble fibronectin was tested by several experiments. Activated platelets adherent to adsorbed mutant fibrinogen lacking the QAGDV sequence (gammadelta5FG) were assembly-competent, as were platelets adherent to adsorbed normal fibrinogen that had been pretreated with the 7E9 antibody to the C terminus of the gamma-chain. Moreover, adsorbed normal fibrinogen but not gammadelta5FG suppressed the ability of co-adsorbed fibronectin to direct assembly of soluble fibronectin by spread platelets. The suppressive effect was lost when a surface of co-adsorbed fibronectin and fibrinogen was pretreated with 7E9. These results support a model in which the engagement of alphaIIb beta3 by the C-terminal sequence of the fibrinogen gamma-chain initiates signals that suppress subsequent fibronectin assembly by spread platelets. This interaction is less dominant when platelets adhere to fibrin, resulting in enhanced fibronectin assembly.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051597     DOI: 10.1074/jbc.M506289200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi.

Authors:  Jaehyung Cho; Deane F Mosher
Journal:  Blood       Date:  2006-01-03       Impact factor: 22.113

2.  Impact of fibronectin assembly on platelet thrombus formation in response to type I collagen and von Willebrand factor.

Authors:  Jaehyung Cho; Deane F Mosher
Journal:  Blood       Date:  2006-05-30       Impact factor: 22.113

3.  Provisional Matrix Deposition in Hemostasis and Venous Insufficiency: Tissue Preconditioning for Nonhealing Venous Ulcers.

Authors:  Tony J Parker; James A Broadbent; Jacqui A McGovern; Daniel A Broszczak; Christina N Parker; Zee Upton
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

4.  Plasma fibronectin supports hemostasis and regulates thrombosis.

Authors:  Yiming Wang; Adili Reheman; Christopher M Spring; Jalil Kalantari; Alexandra H Marshall; Alisa S Wolberg; Peter L Gross; Jeffrey I Weitz; Margaret L Rand; Deane F Mosher; John Freedman; Heyu Ni
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

Review 5.  Emerging roles of fibronectin in thrombosis.

Authors:  Lisa M Maurer; Bianca R Tomasini-Johansson; Deane F Mosher
Journal:  Thromb Res       Date:  2010-02-08       Impact factor: 3.944

6.  The Platelet Integrin αIIbβ3 Differentially Interacts with Fibrin Versus Fibrinogen.

Authors:  Rustem I Litvinov; David H Farrell; John W Weisel; Joel S Bennett
Journal:  J Biol Chem       Date:  2016-02-10       Impact factor: 5.157

Review 7.  Historical perspective and future directions in platelet research.

Authors:  B S Coller
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

Review 8.  Roles of lysophosphatidic acid in cardiovascular physiology and disease.

Authors:  Susan S Smyth; Hsin-Yuan Cheng; Sumitra Miriyala; Manikandan Panchatcharam; Andrew J Morris
Journal:  Biochim Biophys Acta       Date:  2008-06-10

9.  Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood.

Authors:  Valerie Tutwiler; Rustem I Litvinov; Andrey P Lozhkin; Alina D Peshkova; Tatiana Lebedeva; Fazoil I Ataullakhanov; Kara L Spiller; Douglas B Cines; John W Weisel
Journal:  Blood       Date:  2015-11-24       Impact factor: 22.113

10.  Platelet protein disulfide isomerase is required for thrombus formation but not for hemostasis in mice.

Authors:  Kyungho Kim; Eunsil Hahm; Jing Li; Lisa-Marie Holbrook; Parvathy Sasikumar; Ronald G Stanley; Masuko Ushio-Fukai; Jonathan M Gibbins; Jaehyung Cho
Journal:  Blood       Date:  2013-06-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.